Streetbeat News

OPSSF

Opsens Inc

Industry

Electromedical and Electrotherapeutic Apparatus Manufacturing

Open

2.13

Mkt cap

247M

Volume

26K

High

2.14

P/E Ratio

-26.74

52-wk high

2.14

Low

2.12

Div yield

N/A

52-wk low

0.97

Haemonetics has agreed to acquire Opsens for C$2.90 per share in an all-cash transaction, representing a fully diluted equity value of approximately $253M at the current exchange rate.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 10:07 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.